Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ACRX AcelRX Pharmaceuticals Inc

0,86

0,00 (0,00%)

24 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more AcelRX Pharmaceuticals Charts.

AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more AcelRX Pharmaceuticals Charts.

News AcelRX Pharmaceuticals Inc

Form ARS - Annual Report to Security Holders
Montag 29 April 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 29 April 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Montag 29 April 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 19 April 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 15 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 12 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 9 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

AcelRx Announces Rebranding With Name Change to Talphera, Inc.
Dienstag 9 Januar 2024 (5 Monate vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 14 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 13 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 13 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Weitere AcelRX Pharmaceuticals Inc News-Artikel

Leverage DAX X3 Total Re...

Destiny Media Technologies (QB)

KBC Bank NV Kbc Bank x-1...

Societe Generale Effekten

CryptoOracle Collective

BlackRock Municipal Income

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen